A new emphasis on N1 lymph nodes arises in lung resections. More extensive evaluation of N1 lymph nodes may better guide therapy after resections of non-small cell lung cancer (NSCLC) with curative intent. This data comes from the real world. The more N1 stations removed and evaluated, the better it affects further treatment. The presentation took place in New Orleans at MedPage Today.